Literature DB >> 27012630

Partial neurorescue effects of DHA following a 6-OHDA lesion of the mouse dopaminergic system.

Katherine Coulombe1, Martine Saint-Pierre2, Giulia Cisbani3, Isabelle St-Amour4, Claire Gibrat5, Ariane Giguère-Rancourt6, Frédéric Calon7, Francesca Cicchetti8.   

Abstract

Pre-clinical data collected in mouse models of Parkinson's disease (PD) support the neuroprotective potential of omega-3 polyunsaturated fatty acids (n-3 PUFA)-enriched diet on the dopaminergic (DAergic) system. In this study, we investigated the effects of an n-3 PUFA-rich diet using a neurorescue/neurorestorative paradigm. C57BL/6 adult mice were submitted to a striatal stereotaxic injection of the neurotoxin 6-hydroxydopamine (6-OHDA) to induce striatal DAergic denervation and subsequent nigral DAergic cell loss. Three weeks post-lesion, mice received either a docosahexaenoic acid (DHA)-enriched or a control diet for a period of 6 weeks. HPLC analyses revealed a 111% post-lesion increase in striatal dopamine levels in the DHA-fed animals compared to controls (ctrl, P<0.05), although no improvement in the motor behavior was observed. DHA treatment led to a 89% rise in tyrosine-hydroxylase (TH)-immunoreactive terminals within the striatum (P<0.05) in lesioned animals. Despite the fact that DHA did not change the number of TH+ neurons in the substantia nigra pars compacta (SNpc), morphological analyses revealed an increased in perimeters (+7%) and areas (+21%) of DAergic cell bodies in treated animals. Collectively, our results suggest that DHA induces a partial neurorescue/neurorestoration of the DAergic system and support further studies to investigate the potential of a diet-based intervention, or at least the combination of such approach, to current treatments in PD.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  6-Hydroxydopamine; Docosahexaenoic acid; Dopamine; Neurorescue; Neurorestoration; Parkinson's disease

Mesh:

Substances:

Year:  2015        PMID: 27012630     DOI: 10.1016/j.jnutbio.2015.11.014

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  8 in total

Review 1.  Docosahexaenoic Acid: Outlining the Therapeutic Nutrient Potential to Combat the Prenatal Alcohol-Induced Insults on Brain Development.

Authors:  Bradley A Feltham; Xavier L Louis; Michael N A Eskin; Miyoung Suh
Journal:  Adv Nutr       Date:  2020-05-01       Impact factor: 8.701

2.  Neurorestorative effects of sub-chronic administration of ambroxol in rodent model of Parkinson's disease.

Authors:  Akanksha Mishra; Sairam Krishnamurthy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-10-25       Impact factor: 3.000

3.  Astaxanthin and Docosahexaenoic Acid Reverse the Toxicity of the Maxi-K (BK) Channel Antagonist Mycotoxin Penitrem A.

Authors:  Amira A Goda; Khayria M Naguib; Magdy M Mohamed; Hassan A Amra; Somaia A Nada; Abdel-Rahman B Abdel-Ghaffar; Chris R Gissendanner; Khalid A El Sayed
Journal:  Mar Drugs       Date:  2016-11-09       Impact factor: 5.118

4.  Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism.

Authors:  Maricel Gómez-Soler; Begoña Cordobilla; Xavier Morató; Víctor Fernández-Dueñas; Joan C Domingo; Francisco Ciruela
Journal:  Front Neurosci       Date:  2018-08-28       Impact factor: 4.677

Review 5.  The Role of Lipids in Parkinson's Disease.

Authors:  Helena Xicoy; Bé Wieringa; Gerard J M Martens
Journal:  Cells       Date:  2019-01-07       Impact factor: 6.600

Review 6.  Nutraceuticals Targeting Generation and Oxidant Activity of Peroxynitrite May Aid Prevention and Control of Parkinson's Disease.

Authors:  Mark F McCarty; Aaron Lerner
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

Review 7.  Can Natural Products Exert Neuroprotection without Crossing the Blood-Brain Barrier?

Authors:  Manon Leclerc; Stéphanie Dudonné; Frédéric Calon
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

8.  Effect of Docosahexaenoic Acid (DHA) at the Enteric Level in a Synucleinopathy Mouse Model.

Authors:  Jérôme Lamontagne-Proulx; Katherine Coulombe; Fadil Dahhani; Mélissa Côté; Cédric Guyaz; Cyntia Tremblay; Vincenzo Di Marzo; Nicolas Flamand; Frédéric Calon; Denis Soulet
Journal:  Nutrients       Date:  2021-11-24       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.